Zurueck zur Suche

Reporte zur Charge UJ799AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IA 2 GA 1 FL 1

VAERS 2708005

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ799AA

gering
Staat
GA
Alter
0,3
Geschlecht
F
Eingang
01.11.2023
Impfdatum
23.10.2023
Beginn
23.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired pentacel was administered with no reported adverse event; Initial information was received on 23-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 months old female patient to whom expired diphtheria/tetanus/5 hybrid AC pertussis/ipv(vero)/HIB(PRP/T) vaccine [Pentacel (VERO)] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Oct-2023, the patient received a 0.5ml, once dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/ipv(vero)/HIB(PRP/T) vaccine Suspension for injection (lot UJ799AA, expiry date: 02-Oct-2023, strength: standard) via intramuscular route in the left thigh for Immunization and expired pentacel was administered with no reported adverse event (expired product administered) (Latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2641258

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ799AA

gering
Staat
IA
Alter
-
Geschlecht
U
Eingang
06.06.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

patient received pentacel and prevnar vaccines in error with no reported adverse event; Initial information received on 31-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Child of unknown gender who received PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) [PREVNAR 13] and DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] vaccines in error with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a Primary dose of 0.5 ml of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE (Suspension for injection) (lot: UJ799AA) via intramuscular route on left side and the patient also received an unknown dose of suspect PREVNAR 13 not produced by Sanofi Pasteur (formulation; lot number; expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination (immunization). Information regarding batch number will be requested in the case. On an unknown date the patient received pentacel and prevnar vaccines in error with no reported adverse event (wrong product administered) (latency: same day). It was reported, "This was a double scheduled visit with sibling, both children have same initals. Doctor requested vaccines for patient by circling vaccines on enounter (Pentacel and Prevnar-13) on both children, order was entered by nurse, Vaccines were drawn up, documented in chart prior to giving vaccines. Vaccines were given. A: After leaving exam room, I came out to nurses station and another nurse was questioning whether or not the older brother was needing these vaccines. Prompting her to look at the system, seeing that they INVALID. Dr. was notified and Manager notified: Dr. will document and contact parent. Drug rep/ manufacturer will be contacted to see if there will be any adverse effects." Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637013

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ799AA

gering
Staat
IA
Alter
2,0
Geschlecht
M
Eingang
26.05.2023
Impfdatum
22.05.2023
Beginn
22.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error

Symptomtext

received complete 4-dose series of pentacle, they inadvertently received a 5th dose with no reported adverse event; Initial information received on 23-May-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 2-year-old male patient who received complete 4-dose series of pentacle, they inadvertently received a 5th dose with no reported adverse event after receiving diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for Prophylactic vaccination. On 22-May-2023, the patient received 0.5 ml total dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection (strength: unknown) (lot: UJ799AA) (expiry date: 10-Feb-2023) via intramuscular route in the left vastus lateralis. On 22-May-2023 the patient had an event of received complete 4-dose series of pentacle, they inadvertently received a 5th dose with no reported adverse event (extra dose administered) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine. Action taken with diphtheria, tetanus, AC pertussis, IPV and HIB vaccine (Pentacel (Vero)) was not applicable. Outcome: unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2591439

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ799AA

gering
Staat
FL
Alter
0,3
Geschlecht
F
Eingang
04.03.2023
Impfdatum
28.02.2023
Beginn
28.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product dose omission issue

Symptomtext

withdrew the diluent portion and mixed it with the lyophilized vaccine component and it was only 0.2 ml after reconstitution, missed their second dose in the series with no reported adverse event; Initial information received on 28-Feb-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves a 4 months old female patient who reported withdrew the diluent portion and mixed it with the lyophilized vaccine component and it was only 0.2 ml after reconstitution, missed their second dose in the series with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Prophylactic vaccination; and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Prophylactic vaccination. On 28-Feb-2023, the patient missed a dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine (Suspension for injection) (Lot UJ799AA with unknown expiry date, strength, and route) because withdrew the diluent portion and mixed it with the lyophilized vaccine component and it was only 0.2 ml after reconstitution, there was not enough diluent in the vial. Because of this the dose was not able to be used and the patient missed their second dose in the series because it was a home visit and they did not have another dose to give to the patient with no reported adverse event (product dose omission issue). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; ROTATEQ
Allergien
-
Vorherige Impfungen
-